# Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer

> **NCT03042169** · PHASE3 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 6 (actual)

## Conditions studied

- Gastric Adenocarcinoma

## Interventions

- **DRUG:** Preoperative Chemotherapy
- **PROCEDURE:** Surgery
- **DRUG:** Postoperative chemotherapy

## Key facts

- **NCT ID:** NCT03042169
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-25
- **Primary completion:** 2024-08-28
- **Final completion:** 2024-08-28
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** default inclusion
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03042169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03042169, "Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03042169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*